Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Age”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT00975845
What this trial is testing

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

Who this might be right for
Anterior Cruciate Ligament Rupture
RTI Surgical 40
Not applicableStudy completedNCT04853641
What this trial is testing

Impact of Age and BMI on Liver Transplant Outcomes

Who this might be right for
Liver Transplant; ComplicationsPerioperative/Postoperative Complications
University of Pittsburgh 700
Testing effectiveness (Phase 2)UnknownNCT00946374
What this trial is testing

Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

Who this might be right for
Mantle-Cell Lymphoma
Heidelberg University 20
Not applicableStudy completedNCT05371171
What this trial is testing

Management of Skin Graft Donor Site Wound in Aged Patient

Who this might be right for
Skin Regrafting; Donor Site of Skin Grafting; Vancouver Scar Scale
Taipei Medical University WanFang Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT07046078
What this trial is testing

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Who this might be right for
Acute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00984503
What this trial is testing

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Who this might be right for
CicatrixWound Healing
Renovo 102
Not applicableUnknownNCT01602094
What this trial is testing

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Who this might be right for
Measles
Queen Saovabha Memorial Institute 550
Testing effectiveness (Phase 2)Study completedNCT05100212
What this trial is testing

UmBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)

Who this might be right for
Retinopathy of Prematurity
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 146
Not applicableLooking for participantsNCT06025240
What this trial is testing

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

Who this might be right for
Kidney TransplantRenal Transplant FailureKidney Transplant Rejection+5 more
Liverpool University Hospitals NHS Foundation Trust 282
Not applicableStudy completedNCT01318863
What this trial is testing

A Normal Donor Sample Collection Study in Healthy Adults

Who this might be right for
Healthy Normal Volunteers
Astute Medical, Inc. 300
Large-scale testing (Phase 3)Study completedNCT01534481
What this trial is testing

Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants

Who this might be right for
Infant, NewbornInfant, Small for Gestational AgeInfant, Extremely Low Birth Weight
NICHD Neonatal Research Network 483
Not applicableEnded earlyNCT03624192
What this trial is testing

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Who this might be right for
Skin; Deformity
Avita Medical 3
Post-approval studies (Phase 4)UnknownNCT02064777
What this trial is testing

Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation

Who this might be right for
Pediatric Liver Transplantation
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60
Not applicableEnded earlyNCT03233074
What this trial is testing

Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaCardio-vascular Surgery
Centre Hospitalier Universitaire de Saint Etienne 93
Testing effectiveness (Phase 2)Study completedNCT00092404
What this trial is testing

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,210
Not applicableNot Yet RecruitingNCT07666568
What this trial is testing

Younger vs. Older Donors in Allo-HSCT: TTE

Who this might be right for
A Target Trial Emulation StudyDonor AgeALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University 5,000
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Post-approval studies (Phase 4)UnknownNCT01663805
What this trial is testing

Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population

Who this might be right for
Delayed Function of Renal Transplant
MARIO ABBUD FILHO 80
Large-scale testing (Phase 3)Looking for participantsNCT04877288
What this trial is testing

Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Who this might be right for
Renal Allograft Recipients
Bristol-Myers Squibb 102
Not applicableUnknownNCT02855372
What this trial is testing

Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)

Who this might be right for
Lung Transplantation
Assistance Publique Hopitaux De Marseille 800
Next Page
20